Rutherford Crossing Dialysis is a medicare approved dialysis facility center in Winchester, Virginia and it has 13 dialysis stations. It is located in Frederick county at 141 Market Street, Winchester, VA, 22603. You can reach out to the office of Rutherford Crossing Dialysis at (540) 665-5169. This dialysis clinic is managed and/or owned by Davita. Rutherford Crossing Dialysis has the following ownership type - Profit. It was first certified by medicare in January, 2017. The medicare id for this facility is 492704 and it accepts patients under medicare ESRD program.
| Name | Rutherford Crossing Dialysis |
|---|---|
| Location | 141 Market Street, Winchester, Virginia |
| No. of Dialysis Stations | 13 |
| Medicare ID | 492704 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 141 Market Street, Winchester, Virginia, 22603 | |
| (540) 665-5169 | |
| Not Available |
| NPI Number | 1881047637 |
| Organization Name | Rutherford Crossing Dialysis |
| Doing Business As | Total Renal Care, Inc. |
| Address | 141 Market St Winchester, Virginia, 22603 |
| Phone Number | (540) 665-5169 |
| Dialysis patients with Hemoglobin data | 10 |
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 22 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 104 |
| Percentage of adult patients getting regular hemodialysis at the center | 94 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Rutherford Crossing Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 23 |
| Hypercalcemia patient months | 108 |
| Patients with Serumphosphor | 28 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 41 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 13 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 27 |
| Patient months included in arterial venous fistula and catheter summaries | 118 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 81 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
Bio-Medical Applications Of Virginia Inc Location: 38 W. Jubal Early Drive, Winchester, Virginia, 22601 Phone: (540) 535-2254 |
Rutherford Crossing Dialysis Location: 141 Market Street, Winchester, Virginia, 22603 Phone: (540) 665-5169 |